Invention Grant
- Patent Title: Substituted imidazopyridazines useful as kinase inhibitors
- Patent Title (中): 用作激酶抑制剂的取代的咪唑并哒嗪
-
Application No.: US12866365Application Date: 2009-02-06
-
Publication No.: US08389527B2Publication Date: 2013-03-05
- Inventor: Brian E. Fink , Soong-Hoon Kim , Yufen Zhao , Ping Chen , Wayne Vaccaro , Litai Zhang , Ashvinikumar V Gavai , Dharmpal S Dodd , Libing Chen
- Applicant: Brian E. Fink , Soong-Hoon Kim , Yufen Zhao , Ping Chen , Wayne Vaccaro , Litai Zhang , Ashvinikumar V Gavai , Dharmpal S Dodd , Libing Chen
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu
- International Application: PCT/US2009/033455 WO 20090206
- International Announcement: WO2009/100375 WO 20090813
- Main IPC: A01N43/58
- IPC: A01N43/58 ; A01N43/60 ; C61K31/50 ; C07D487/00
Abstract:
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I imidazopyridazines inhibit protein kinase activity thereby making them useful as anticancer agents.
Public/Granted literature
- US20100323994A1 SUBSTITUTED IMIDAZOPYRIDAZINES USEFUL AS KINASE INHIBITORS Public/Granted day:2010-12-23
Information query
IPC分类:
